IRIX: the cash flow

MyFinsight

For the year ending 2026-01-03, IRIX had $3,641K increase in cash & cash equivalents over the period. -$2,258K in free cash flow.

Cash Flow	2026-01-03
Net loss	-4,437
Loss on inventory write-down	823
Loss on extinguishment of convertible note payable	-1,335
Depreciation and amortization	523
Amortization of operating lease right-of-use assets	1,024
Accretion of original issue discount	-58
Amortization of debt issuance costs	169
Stock-based compensation	775
Accounts receivable	1,662
Receivable from related party	-511
Inventories	-2,117
Prepaid expenses and other current assets	-162
Other long-term assets	-270
Accounts payable	-1,954
Payable to related party	-492
Accrued compensation	668
Accrued expenses	131
Deferred revenue	-1,565
Operating lease liabilities	-1,108
Other liabilities	537
Net cash used in operating activities	-2,115
Acquisition of property and equipment	143
Net cash used in investing activities	-143
Net proceeds from issuance of convertible note payable	4,000
Cash paid for debt issuance costs	0
Proceeds for stock option exercises	0
Payments on convertible note payable	3,961
Proceeds from issuance of series b convertible preferred stock	6,000
Taxes paid related to net share settlements of equity awards	75
Net cash provided by financing activities	5,964
Effect of foreign exchange rate changes	-65
Net increase (decrease) in cash and cash equivalents	3,641
Cash and cash equivalents, beginning of period	2,387
Cash and cash equivalents, end of period	6,028

Unit: Thousand (K) dollars (except for numbers of shares and EPS).